RPID
Rapid Micro Biosystems, Inc.
$1.72
+0.01 (+0.58%)
At close · Jul 2
Market Cap
$87.29M
Shares
46,169,202
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.72
Open$1.73
Day$1.68–1.75
52W$1.66–4.94
Avg vol 30d158K
Short int614K · 1.3% float · 4.9d
Short vol37%
Last earningsMay 13, 2026
DataJul 2021–Jul 2026
Filing10-Q · May 15
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−44% below
−
Price vs 50-day avg
−17% below
◦
RSI (14)
36 · neutral
+
MACD trend
positive
−
52-week position
2% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $2 › 200d $3 — 200d above 50d
+
Institutional flow
+10% holders QoQ · +13 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
1.33% of float · ▼ -18.0% MoM · 4.9 days cover
◦
Volume signal
Volume near normal
+
Institution breadth
46 holders — near 3-yr high, broad support
Fundamentals
Strong
+
Revenue growth
+20% Y/Y
◦
EPS growth
+3% Y/Y
−
Free cash flow
$-31.9M
+
Balance sheet
net cash $20.0M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 12, 2026
Est · unconfirmed
· in 5 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance & track record
Latest guidance
· from the 8-K filed May 13, 2026
Total revenue
· full year 2026
Initiated
$37M – $41M
prior FY $33.59M
midpoint +16.1% Y/Y
Gross margin percentage
· full year 2026
Initiated
20%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−44% below
Bearish
Price vs 50-day avg
−17% below
Bearish
RSI (14)
36 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
2% · near low
Bearish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
+10% holders QoQ · +13 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.33% of float · ▼ -18.0% MoM · 4.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
46 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $2
Now $2 · 2%
52-wk high $5
vs 200-day avg -44%
vs 50-day avg -17%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Consumable gross margin percentage change | 33% | Q1 2026 | — |
| Growth Direct system placements | 6 | Q1 2026 | — |
| Product gross margin percentage change | 15% | Q1 2026 | — |
| Recurring revenue as a percentage of total revenue | 63% | Q1 2026 | — |
| Cumulative systems placed | 190 | full year 2025 | — |
| Cumulative systems validated | 155 | full year 2025 | — |
| Customer systems validated | 18 | full year 2025 | — |
| Growth Direct systems placed | 28 | full year 2025 | — |
| Non-GAAP adjusted total gross margin percentage non-GAAP | 6% | full year 2025 | — |
| new Growth Direct systems placed | 28 | full year 2025 | — |
| recurring revenue | $17.8M | full year 2025 | — |
| systems placed globally | 190 | cumulative | — |
| systems validated | 155 | cumulative | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RPID
this stock
Rapid Micro Biosystems, Inc.
|
$87.29M | -40.7% | +19.7% | — | 1.3% |
|
ABT
Abbott Laboratories
|
$166.17B | -23.5% | +5.7% | 26.7 | 1.3% |
|
SYK
Stryker Corp
|
$125.18B | -6.8% | +11.2% | 37.8 | 1.6% |
|
MDT
Medtronic plc
|
$106.49B | -12.7% | +8.4% | 22.3 | 1.4% |
|
BSX
Boston Scientific Corp
|
$67.09B | -52.7% | +5.5% | 18.9 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RPID | +1.2% | -12.2% | -47.0% | -0.6% | -40.7% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -0.3% | -11.0% | -55.0% | -0.3% | -49.9% |